Share Repurchase Programme
(MENAFN- GlobeNewsWire - Nasdaq) Nørresundby, 4 April 2024
Announcement no.20/2024
The Board of Directors of RTX has, cf. company announcement no. 20/2023 dated 30 November 2023, resolved to initiate a share buy-back programme in accordance with the provisions of Article 5 Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and the Commission's delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbor" regulation.
Under the programme RTX will buy back shares for an amount up to DKK 20 million in the period from 1 December 2023 to 30 September 2024.
The following transactions have been made under the programme in the period below:
| | Number of Shares | Average Purchase Price | Transaction value in DKK |
| RTX shares prior to initiation of the programme | 258,528 | | |
| Accumulated share in the programme, latest announcement | 140,829 | | 11,735,880 |
| 22 March 2024 | 1,032 | 94.20 | 97,214 |
| 25 March 2024 | 500 | 95.00 | 47,500 |
| 26 March 2024 | 1,179 | 96.44 | 113,703 |
| 27 March 2024 | 1,500 | 96.23 | 144,345 |
| 2 April 2024 | 1,341 | 97.62 | 130,908 |
| 3 April 2024 | 1,300 | 98.78 | 125,294 |
| Accumulated under the programme | 147,681 | 83.93 | 12,394,844 |
| | | | |
| RTX total shares | 8,467,838 | | |
| RTX Treasuty shares | 406,209 | 4.8% | of share capital |
In accordance with the Regulation (EU) No. 596/2014, transactions related to the share buy-back programme are presented in detailed form in the appendix attached to this company announcement.
Enquiries and further information:
CEO Peter Røpke, tel +45 96 32 23 00
Attachment
RTX CA No 20-2024 - 04.04.24 - Share repurchase programme
MENAFN04042024004107003653ID1108059070
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.